Skip to content
Clinical Trials – home
HungaryBack to Hungary

Clinical trials in Dunaújváros – page 14

198 clinical trials in Dunaújváros, Hungary across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

Dunaújváros at a glance
198
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

198 trials in Dunaújváros

Open in trial search

Hypertension

Not recruiting

Study on Baxdrostat for Reducing Blood Pressure in Patients with Uncontrolled or Resistant Hypertension

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Baxdrostat
  • Sponsor:Astrazeneca AB

Cardiac failure

Not recruiting

Study of XXB750 and Drug Combination for Patients with Heart Failure

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Azilsartan Medoxomil
  • Sponsor:Novartis Pharma AG

Hypertension

Not recruiting

Study on Baxdrostat for Lowering Blood Pressure in Patients with Resistant Hypertension

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Baxdrostat
  • Sponsor:Astrazeneca AB

Rheumatoid arthritis

Not recruiting

Study on Burfiralimab for Patients with Moderate to Severe Rheumatoid Arthritis

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Burfiralimab
  • Sponsor:Immunemed Inc.

Psoriatic arthropathy

Not recruiting

Study on Guselkumab for Treating Active Psoriatic Arthritis in Patients with Inadequate Response to One Prior Anti-TNF Agent

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Guselkumab
  • Sponsor:Janssen - Cilag International

Study on AVP-786 for Treating Agitation in Alzheimer's Dementia Patients

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Quinidine Sulfate
  • Sponsor:Otsuka Pharmaceutical Development & Commercialization Inc.

Study of Datopotamab Deruxtecan and Pembrolizumab for Patients with Advanced or Metastatic Non-small Cell Lung Cancer Without Actionable Genomic Alterations

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:Daiichi Sankyo Inc.

Sepsis+1

Not recruiting

Study on the Safety and Effectiveness of TIN816 for Patients with Sepsis-Related Acute Kidney Injury

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:TIN816
  • Sponsor:Novartis Pharma AG

Cardiac failure chronic+1

Not recruiting

Study on the Safety of Starting Vericiguat at 5 mg in Patients with Chronic Heart Failure with Reduced Ejection Fraction

InvestigationalNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Vericiguat
  • Sponsor:Bayer AG

Study Comparing Subcutaneous and Intravenous Isatuximab with Pomalidomide and Dexamethasone for Adults with Relapsed or Refractory Multiple Myeloma

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:65+ years
  • Substances:Dexamethasone
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Study of Secukinumab for Maintaining Remission in Patients with Non-Radiographic Axial Spondyloarthritis

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Secukinumab
  • Sponsor:Novartis Pharma AG

Study Comparing Pirtobrutinib to Bendamustine and Rituximab for Untreated Patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Pirtobrutinib
  • Sponsor:Loxo Oncology Inc.

Other cities in Hungary

The busiest research cities in the country

All 73 cities in Hungary

Clinical research in Dunaújváros

What the registry says about research in the country

01 Cardiovascular and Stroke Research

Innovative trials focusing on atherosclerotic cardiovascular disease prevention and stroke treatment, evaluating new therapeutic approaches for reducing major cardiovascular events.

  • Primary ASCVD Prevention
  • Acute Ischemic Stroke
  • High-Risk TIA Management

Studies aim to demonstrate the effectiveness of novel compounds in preventing cardiovascular complications and improving stroke outcomes.

02 Renal and Metabolic Disorders

Research examining combination therapies for chronic kidney disease with concurrent hypertension, exploring innovative treatment approaches for better patient outcomes.

  • CKD Management
  • Hypertension Control
  • Primary Biliary Cholangitis

Trials focus on evaluating new medications to slow disease progression and improve quality of life.

03 Neurological and Pain Management

Studies investigating novel treatments for episodic migraine, focusing on preventive therapies to reduce headache frequency and severity.

  • Migraine Prevention
  • Headache Management

Research aims to develop effective preventive treatments for patients suffering from recurring migraines.

04 Gastrointestinal and Inflammatory Conditions

Clinical investigations of new therapies for ulcerative colitis, examining both short-term improvement and long-term maintenance treatments.

  • Inflammatory Bowel Disease
  • UC Management
  • Long-term Disease Control

Studies evaluate novel compounds for achieving endoscopic improvement and symptomatic remission.

05 Wound Healing and Regenerative Medicine

Innovative research utilizing stem cell therapy for treating chronic venous ulcers, focusing on wound healing in difficult-to-treat cases.

  • Chronic Wound Management
  • Regenerative Medicine
  • Venous Ulcer Treatment

Trials explore advanced therapeutic approaches for non-healing wounds using cellular treatments.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.